Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Vormehr

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Human Vaccines & Immunotherapeutics|July 21, 2016
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, GermanyLena M Kranz, Matthias Birtel, Lina Hilscher, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
BMC Cancer|September 15, 2019
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic miceKrishna Das, David Eisel, Mathias Vormehr, et al.
Frontiers in Oncology|August 15, 2020
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor ModelBarbara Schrörs, Sebastian Boegel, Christian Albrecht, et al.
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Human Vaccines & Immunotherapeutics|July 18, 2015
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyLena M Kranz, Matthias Birtel, Christina Krienke, et al.
Oncoimmunology|September 14, 2020
Dexamethasone premedication suppresses vaccine-induced immune responses against cancerMathias Vormehr, Sophie Lehar, Lena M Kranz, et al.
Cancer Cell|August 13, 2024
Long-lasting mRNA-encoded interleukin-2 restores CD8<sup>+</sup> T cell neoantigen immunity in MHC class I-deficient cancersJan D Beck, Mustafa Diken, Martin Suchan, et al.
Cancer Cell|March 15, 2024
Long-lasting mRNA-encoded interleukin-2 restores CD8<sup>+</sup> T cell neoantigen immunity in MHC class I-deficient cancersJan D Beck, Mustafa Diken, Martin Suchan, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Human Vaccines & Immunotherapeutics|July 21, 2016
CIMT 2016: Mechanisms of efficacy in cancer immunotherapy - Report on the 14th Annual Meeting of the Association for Cancer Immunotherapy May 10-12 2016, Mainz, GermanyLena M Kranz, Matthias Birtel, Lina Hilscher, et al.
Oncoimmunology|May 31, 2019
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell responseFulvia Vascotto, Jutta Petschenka, Kerstin C Walzer, et al.
BMC Cancer|September 15, 2019
A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic miceKrishna Das, David Eisel, Mathias Vormehr, et al.
Frontiers in Oncology|August 15, 2020
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor ModelBarbara Schrörs, Sebastian Boegel, Christian Albrecht, et al.
Oncoimmunology|September 14, 2020
A liposomal RNA vaccine inducing neoantigen-specific CD4<sup>+</sup> T cells augments the antitumor activity of local radiotherapy in miceNadja Salomon, Fulvia Vascotto, Abderaouf Selmi, et al.
Frontiers in Immunology|March 27, 2023
MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expressionBarbara Schrörs, Brett J Hos, Ikra G Yildiz, et al.
Human Vaccines & Immunotherapeutics|July 18, 2015
CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer ImmunotherapyLena M Kranz, Matthias Birtel, Christina Krienke, et al.
Oncoimmunology|September 14, 2020
Dexamethasone premedication suppresses vaccine-induced immune responses against cancerMathias Vormehr, Sophie Lehar, Lena M Kranz, et al.
Cancer Cell|August 13, 2024
Long-lasting mRNA-encoded interleukin-2 restores CD8<sup>+</sup> T cell neoantigen immunity in MHC class I-deficient cancersJan D Beck, Mustafa Diken, Martin Suchan, et al.
Cancer Cell|March 15, 2024
Long-lasting mRNA-encoded interleukin-2 restores CD8<sup>+</sup> T cell neoantigen immunity in MHC class I-deficient cancersJan D Beck, Mustafa Diken, Martin Suchan, et al.
Pageof 4